Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Ethnicity & Disease|December 2, 2005
Cardiovascular disease event classification in the Jackson Heart Study: methods and proceduresEmmanuel Keku, Wayne Rosamond, Herman A Taylor, et al.Journal of the National Medical Association|February 22, 2005
African-American women's perceptions of their most serious health problemsGeorgia Robins Sadler, Rita Paola Escobar, Celine Marie Ko, et al.The Journal of Urology|April 17, 2012
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivityDavid Ginsberg, Angelo Gousse, Veronique Keppenne, et al.Digital Health|November 6, 2023
Examining motivation factors for African American students' use of consumer wearablesMonique White, Shelia Malone, Girmay Berhie, et al.AIMS Public Health|January 8, 2024
Mississippi church leaders' perceptions of challenges and barriers to the use of consumer wearables among community membersMonique White, Candis Pizzetta, Edith Davidson, et al.Neurourology and Urodynamics|November 27, 2015
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension studyMichael Kennelly, Roger Dmochowski, Heinrich Schulte-Baukloh, et al.The Australian Journal of Rural Health|February 10, 2025
How Is Chronic Pain Managed in Rural Australia? A Qualitative Study Exploring Rural Healthcare Professional and Consumer ExperiencesAshley R Grant, Gill Westhorp, Amelia Mardon, et al.Neurology|July 22, 2018
Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MSMark Tullman, Emmanuel Chartier-Kastler, Alfred Kohan, et al.The Journal of Urology|April 4, 2016
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year StudyVictor W Nitti, David Ginsberg, Karl-Dietrich Sievert, et al.Advances in Therapy|September 28, 2013
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiologyDavid Ginsberg, Francisco Cruz, Sender Herschorn, et al.Pageof 5